In Alzheimer's disease, the C3a/C3aR pathway mediated microtubule-associated protein tau modulation by targeting STAT3, and the expression of C3aR was negatively correlated with cognitive function and positively correlated with Braak stages (10). The gene discussed is C3AR1; the disease is early-onset autosomal dominant Alzheimer disease.